JNJ-1013 |
| Catalog No.GC69316 |
JNJ-1013 est un inhibiteur de dégradation sélectif efficace d'IRAK1, avec des valeurs IC50 respectives de 72, 443 et 1071 nM pour IRAK1, IRAK4 et VHL FP. JNJ-1013 induit l'apoptose cellulaire et augmente l'expression de PARP clivé. JNJ-1013 réduit l'expression d'IRAK1, p-IKBα et pSTAT3(Tyr705).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2597343-08-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for JNJ-1013
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for JNJ-1013
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *